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ABSTRACT 
Polymerized liposomes encapsulating L-tryptophan were studied with the aim to characterize them as drug delivery 
systems for the treatment of several metabolic diseases that need an increased systemic L-tryptophan concentration. 
polymerized liposomes were obtained by UV irradiation of vesicles containing 1,2-bis(10,12-tricosadiynoyl)-sn-glyc- 
ero-3-phosphocholine (DC8,9PC) and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) in a 1:1 molar ratio, in the 
presence of 10 and 50 mol% of L-tryptophan (respect to total lipid concentration). Polymerization efficiency was stud- 
ied spectrophotometrically. Also, bilayer packing at the polar head region was followed with the Merocyanine 540 
(MC540) and specific interactions in the lipopolymers were studied by FTIR. High L-tryptophan concentrations (50 
mol% respect to total lipid concentration) induced a higher amount of six- and nine-unit polymers. This phenomenon 
was induced because the L-tryptophan located outside the lipid membrane was included in it during the polymerization 
process and was thus responsible for the better accommodate of the polar head region. This was not possible with the 
lower amount of L-tryptophan (10 mol%). The stability of lipopolymers with different amounts of L-tryptophan was 
studied through release profiles. Polymerized liposomes with 50 mol% of L-tryptophan were able to retain around 80% 
of the amino acid after 24 hours, whereas those with 10 mol % of the amino acid were able to retain 20%. The meta- 
bolic activity of the Caco-2 cell line was also studied. Cytotoxic effects were low in the presence of polymerized lipo- 
somes, rendering a maximum percentage of cell death of 30%. In summary, this work stresses the relevance of nonspe- 
cific drug-polymerized membrane binding on L-tryptophan pharmacological interaction with possible pharmaceutical 
applications in liposomal drug delivery. Moreover, the absence of significant cytotoxic effects allows the system pro- 
posed to be applied in human health.  
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1. Introduction 
Liposomes, which are useful drug delivery systems, have 
been used to deliver not only small molecules [1] but 
also macromolecules such as proteins [2] and DNA [3]. 
polymerized liposomes can be obtained by a photopoly- 
merization process. Since photo-polymerizable lipids 
combine the plasticity of lipids with the robustness of 
polymers, they have received much attention in several 
biological areas [4]. Research of lipopolymers as tools to 
be applied in biomedical science started in the early 
1980s [5]. Design of lipopolymers relies on two advan- 
tages: lipid self-assembly properties and photoactivable 
bonds in photopolymerizable lipids [6]. Lipopolymers 
have many potential applications in medicine since they  
have a great stability. Polymerizable lipids contain a di- 
acetylene moiety along their acyl chain. These lipids can 
be polymerized by UV irradiation to form chains of co- 
valently linked lipids in the bilayer. Closely packed and 
properly ordered, diacetylene lipids undergo polymeriza- 
tion via 1,4-addition to form alternating ene-iyne poly- 
mer chains upon irradiation with 254 nm light [7]. Lipo- 
polymers can aggregate into a variety of vesicular and 
non-vesicular assemblies depending on the lipid concen- 
tration, structure and processing conditions [8].  
L-tryptophan, an essential amino acid, is a vital con- 
stituent of proteins and indispensable in human nutrition 
for maintaining a positive nitrogen balance [9]. It has an 
amphiphilic character due to the hydrophobic indole ring 
structure and the hydrophilic amino acid part [10]. Indole, 
the aromatic side chain element of L-tryptophan, seems *Corresponding author. 
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to play many biological roles, as an anchor or organizing 
element or as a hydrogen bond donor [11]. L-tryptophan 
is also a serotonin precursor and can thus affect behav-
ioral patterns such as food consumption and sleeping.  
Regarding L-tryptophan interaction with liposomes, 
when this amino acid is in a membrane protein, it dis-
plays strong preference for the lipid membrane interface 
and is very important for anchoring proteins at the proper 
longitudinal level. Indole’s prefer to orient themselves 
with their nitrogen pointing towards the hydrophilic part 
of the membrane. The long-axis of indole’s points pref-
erentially in the direction of the membrane plane as de-
picted in Figure 1 [12,13].   
According to Popova A. and Hincha D. (2004), L- 
tryptophan destabilizes both biological and model mem- 
branes during freezing. The degree of destabilization of 
L-tryptophan, especially at low L-tryptophan concentra- 
tions, depends on the lipid composition of the membrane. 
Membranes made up entirely of phosphatidylcholine or 
with a mixture of phosphatidylcholine and phosphati- 
dylethanolamine are very strongly affected, while much 
less destabilization is observed for galactolipid-contain- 
ing liposomes [14].  
The initial observation that physiological changes in 
tryptophan availability after food consumption could af-
fect serotonin synthesis derives from studies in rats per-
formed in 1971 [15]. However, direct evidence suggesting 
that variations in tryptophan concentrations affect sero-
tonin release was not obtained until 1987, when it was 
reported that the rate at which serotonin is released from 
hypothalamic nerve terminals is coupled to brain trypto-
phan levels. Accelerations in hypothalamic serotonin 
synthesis, caused by increasing brain tryptophan levels, 
result in proportionate increases in the rates of serotonin 
release during rest with membrane depolarization [16]. 
Also, since L-tryptophan is a serotonin precursor, it 
has an anorectic effect and is highly related to anxiety 
control, stress and insomnia [17]. Brain serotonin appears 
to be an excellent target for designing drugs to treat obe- 
sity. The special importance of serotoninergic neurons in 
feeding behavior derives in part from the fact that eating  
 
 
Figure 1. Scheme of polymerization reaction. 
per se affects the production and release of serotonin. 
This is because dietary carbohydrates, acting via insulin, 
decrease the plasma concentrations of large neutral 
amino acids and increase the uptake of tryptophan in the 
brain. This, in turn, increases the substrate saturation of 
tryptophan hydroxylase, the key enzyme that converts 
this amino acid to serotonin. Paradoxically, dietary pro- 
teins—which, unlike carbohydrates or fats, do contain 
tryptophan—decrease tryptophan’s uptake in the brain 
(because they cause disproportionately great increases in 
blood levels of other large neutral amino acids, which 
compete with tryptophan for brain uptake), and thus fail 
to increase brain tryptophan or serotonin levels [18]. So, 
the increase in the systemic concentration of pure L- 
tryptophan could be considered as a possible therapy to 
treat a problem such as obesity.  
Thus, obtaining a liposome system that could deliver 
L-tryptophan and increase the concentration gradient 
after oral inoculation will probably lead to an alternative 
therapy to treat obesity from a behavioral point of view. 
To achieve this, goal it is first necessary to study and 
characterize the lipid vehicles from a biophysical and a 
biochemical point of view. Therefore, the main goal of 
this work was to obtain polymerized liposomes that can 
encapsulate L-tryptophan and study some relevant pa- 
rameters such as polymerization efficiency, structure, 
release of L-tryptophan and influence on cell metabo- 
lism.   
2. Materials and Methods  
2.1. Materials  
Lipids were purchased from Avanti Polar Lipids (Ala- 
bama, USA) and used without further purification. Re- 
agents used in cell culture were purchased from GIBCO 
(USA). All solvents were of analytical grade or higher.  
2.2. Liposome and Polymer Preparation 
Lipids (6.4 µmol, 5.2 mg) were dissolved in chloroform; 
the solvent was flash-evaporated and left under vacuum 
for 30 min [19]. Large multilamellar vesicles (LMVs) 
were obtained by adding 2 mL of phosphate buffered 
saline (PBS) pH 7.4 (with or without L-tryptophan). UV 
irradiation was accomplished with a Stratalinker 1800 to 
cross-link and polymerize the diacetylenic LMVs. Po- 
lymerization was performed as previously described [3,8, 
20-23]. Briefly, polymerization cycles were of 360,000 
mJ/cm2, each of 1650s (15 cycles in total), at a wave- 
length of 254 nm. Temperature was kept at 4˚C in be- 
tween cycles. LMVs concentration was kept at 2 mg/ml. 
The spectra were recorded at different polymerization 
cycles, in particular at 0, 1, 5, 10 and 15. Visible spectra 
were recorded on a Shimadzu 160-A double beam spec- 
trophotometer, between 400 and 600 nm for both polym- 
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erized and non-polymerized liposomes.  
2.3. L-Tryptophan Incorporation 
L-tryptophan was dissolved in PBS and incorporated in 
the dry lipid film. Two concentrations were tested: 10 
and 50 mol% relative to total lipid concentration.   
2.4. In Vitro Release of L-Tryptophan 
The L-tryptophan releasing profile of polymerized lipo- 
somes was studied in PBS. Non-encapsulated L-trypto- 
phan was separated by centrifugation [20]. Polymerized 
liposomes with 10 and 50 mol% of L-tryptophan were 
prepared as described above and 0.2-mL aliquots were 
withdrawn at different times. The lipid suspension was 
incubated for 24 h at 37˚C under constant agitation. After 
each sample withdrawing, an aliquot of PBS was added 
to maintain the original concentration gradient. L-tryp- 
tophan was spectrophotometrically quantified from the 
supernatant by using a UV-visible spectrophotometer Nano- 
drop 1000 (Thermoscientific, USA). Absorbance was mea- 
sured at 280 nm.    
The release percentage was determined by the follow- 
ing equation:  
    TL % TLt TLt 1 100 TT     
where TLt is the concentration of L-tryptophan released 
at different times, TLt-1 is the concentration of L-tryp- 
tophan released in the previous sample (this was added to 
avoid error of the concentration gradient) and TT is the 
total L-tryptophan concentration added to polymerized 
liposomes. An aliquot was withdrawn immediately after 
preparation and it was used to calculate the % of encap- 
sulation.  
2.5. Surface Modifications 
To determine the spectral characteristics of the mem-
brane/solution interface, the visible spectra of the probe 
merocyanine 540 (MC540) was recorded between 400 
and 600 nm at 10˚C to maintain the gel phase because 
this is the structure needed for the polymerization reac- 
tion. The MC540 probe is sensitive to the polar environ- 
ment. In water, the spectra show two maxima (a dimer at 
500 nm and a monomer at 530 nm). In a hydrophobic 
environment, the maximum is shifted towards 530 nm 
(MC540 dimer) and 570 nm (MC540 monomer). The 
first two are the characteristic absorbance maxima when 
the membrane is in the gel phase, whereas the second 
two are the characteristic absorbance maxima when the 
membrane is in liquid crystalline [24]. The ratio of the 
absorbance at 570 nm with respect to 500 nm, called hy- 
drophobicity factor (HF) [22], determines the degree of 
hydrophobic sites exposed to the interface. The MC540 
stock concentration was approximately 1 mg/ml. MC540, 
freshly prepared, was added in aliquots to give a final 
concentration of 10 - 6 M. The lipid/ probe ratio was kept 
at (160:1). The sample was allowed to equilibrate for 2 
min at 15˚C to keep lipids in gel phase, and then meas-
ured. To avoid scattering, LMVs without MC540 were 
used as reference. The lipid concentration was kept at 2 
mg/ml for the polymerization process and 0.6 mg/ml for 
the measurements of the visible spectra. HF was meas-
ured in samples with 0, 1, 5, 10 and 15 polymerization 
cycles.  
2.6. FTIR Spectroscopy 
Fourier-transform infrared (FTIR) spectroscopy was used 
to study the interaction between lipopolymers and L- 
tryptophan as well as the changes induced by the polym- 
erization process. To this end, 0.4 mL of the liposomal 
suspension with or without L-tryptophan or polymeriza- 
tion were pipetted onto ATR cells and dried with a hair 
drier. Infrared spectra were recorded from 3000 to 1000 
cm−1 in an IRAffinity-1 Fourier Transform Infrared spec-
trometer (Shimadzu). Data were analyzed, normalized 
and baseline corrected with the IRsolution software 
(Shimadzu). Frequencies were determined by the peak 
identification routine of the software.  
2.7. Cell Metabolism Activation and Cytotoxicity 
To study the influence of the delivery systems proposed 
on a cell culture and analyze if there is any cytotoxic 
effect, the Caco-2 cell line, a human cell line derived 
from a colon adeno carcinoma [25], was selected. This 
cell line, which is widely used in assays that involve drug 
absorption related to an oral route, was selected because 
its characteristics are similar to those of the absorptive 
intestinal epithelium [26]. Several concentrations of po- 
lymerized liposomes with 10 and 50 mol% of L-trypto- 
phan (relative to total lipid concentration) were seeded in 
confluent cell culture. Briefly, Caco-2 cells were seeded 
in a 96-well plate. Cells were grown in minimum essen- 
tial medium (MEM) enriched with 15% v/v of bovine 
fetal serum (BFS), 10 mM sodium pyruvate and a com- 
bination of antibiotics and antimycotics. All reagents 
were purchased from GIBCO (USA). Cells were allowed 
to grow at 37˚C in a 5% CO2 atmosphere. Upon cell con-
fluence, liposomes were seeded in maintenance medium 
(without BFS). After 4 or 24 hours, the medium was 
washed and an MTT assay was performed. Cell viability, 
which depends on metabolic processes, especially mito- 
chondrial respiratory chain, can be evaluated by studying 
mitochondrial dehydrogenases. MTT is a colorimetric 
reagent, which turns yellow when oxidized and purple 
after reduction by mitochondrial enzymes. Absorbance at 
570 nm is a quantitative analysis used to detect reduced 
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MTT [27]. The MTT assay was performed in Caco-2 
cells treated with polymerized liposomes with 10 and 50 
mol% of L-tryptophan. The lipid concentration was kept 
at 1 mg/ml. Reduced MTT by cells treated with polym-
erized liposomes or L-tryptophan was also measured. 
Cells without liposomes or L-tryptophan were used as 
controls.     
3. Results and Discussion   
Understanding the structure and function of lipid mem- 
branes at the interface is a major challenge in the field of 
biophysics and requires a combination of structural and 
functional methods.   
L-tryptophan is a serotonin precursor, has an anorectic 
effect and is highly related to anxiety control, stress and 
insomnia [16], all of which are extremely important fac- 
tors in human nutrition. Even more, if the L-tryptophan is 
carried by an adequate oral delivery vehicle, like DMPC: 
DC8, 9PC 1:1 mol ratio [3,8,14,19,20,27]. Polymeriza- 
tion of diacetylenic phospholipids implies the formation 
of intra- and intercatenary bonds. Polymers so obtained 
are highly colored due to their highly conjugated struc-
tures [28]. The polymerization degree is determined by 
absorbance spectra, while the position of these peaks is 
related to the number of polymeryzed units that are ef-
fectively conjugated. The number of these polymerized 
units can be calculated as previously described [29]. For 
diacetylenic polymers mixed with DMPC as saturated 
lipid at a 1:1 lipid molar ratio, there are two populations: 
one with six polymeric units (maximum at 480 nm) and 
another one with nine polymerized units (maximum at 
520 nm) [14].    
3.1. Polymerization Degree 
To study the influence of L-tryptophan on polymer for- 
mation, spectra of samples with and without L-trypto- 
phan were recorded after 0, 1, 5, 10 and 15 cycles of po- 
lymerization. Figure 2 depicts absorbance at 480 nm (a) 
and 520 nm (b) as a function of polymerization cycles.   
The data obtained showed that samples with high 
concentration of L-tryptophan polymerized more effi- 
ciently than those with low concentration. In the case of 
the six-unit polymers (Figure 2(a)), 10 mol% of L-tryp- 
tophan induced a better polymerization but only at the 
beginning of the process; after 15 cycles, the concentra-
tion of six-unit polymers with 10 mol% was the same as 
that without L-tryptophan addition. Regarding nine-unit 
polymers (Figure 2(b)), 10 mol% of L-tryptophan had 
no influence in the polymerization efficiency. A concen- 
tration of 50 mol% of L-tryptophan induced a better po- 
lymerization in both six- and nine-unit polymers.  
A more efficient polymerization may be achieved 
when the more ordered acyl lipid chains are aligned  
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Figure 2. Polymerization degree. Figure 1 shows absorb- 
ance at 480 nm (a) corresponding to six polymerized units 
effectively conjugated and at 520 nm (b) corresponding to 
nine polymerized units effectively conjugated as a function 
of polymerization cycles. Data are presented as mean ± SD 
of four independent experiments.  
 
closer to each other, improving the chemical topotactic 
reaction.  
Several authors have reported that L-tryptophan can 
interact with the lipid interphase [13]. A high concentra- 
tion of L-tryptophan can induce a better polymerization 
during the process when the amino acid keeps entering 
the interface from the aqueous medium. This is possible 
because in between UV cycles, samples are incubated at 
4˚C, so lipid membranes can be reorganized and L-tryp- 
tophan in solution can have access to the interface. A 
concentration of 10 mol% respect to total lipid is not 
enough to produce this effect, and polymerization is not 
different from controls.  
To gain insights into the polymerization process in re- 
lation with liposome structure, particularly surface pack- 
ing, the MC540 probe was used and HF was determined. 
Results are shown in Figure 3.  
With high L-tryptophan concentrations (50 mol% rela- 
tive to total lipid concentration), HF decreased. With  
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Figure 3. Hydrophobicity factor (HF). Figure 2 shows the 
HF (Absorbance at 570 nm/Absorbance at 500 nm) as a 
function of the polymerization cycles. Data are presented as 
mean ± SD of four independent experiments.  
 
10 mol% of L-tryptophan, surface packing showed no 
changes in comparison with liposomes without L-tryp- 
tophan. All preparations were subjected to 15 polymeri- 
zation cycles. In a previous work [14], we found that 
only a maximum of 20% of the monomers are polymer- 
ized at the end of the polymerization process and that no 
further polymerization can be achieved by continuous 
irradiation of the DC8, 9PC:DMPC mixture [8,30]. The 
binary system DC8, 9PC:DMPC should be considered as 
a ternary one after UV irradiation, conformed by DMPC 
molecules and monomeric and polymerized units of DC8, 
9PC. DC8, 9PC polymers represent small segregated 
domains that can be found in DMPC and DC8, 9PC-rich 
regions [14]. 
It has been reported that L-tryptophan has a specific 
orientation in model lipid membranes [13,31]. L-trypto- 
phan displays strong preference for the lipid membrane 
interface; in particular, indole prefers to orient with its 
nitrogen pointing towards the hydrophilic part of the 
membrane and its long-axis in the direction of the mem-
brane plane [13]. This specific location could be respon-
sible for the increase in surface packing. Regarding the 
data obtained, the higher L-tryptophan concentration 
induced higher packing and polymerization efficiency. It 
is probable that L-tryptophan prefers DMPC-enriched 
domains rather than DC8, 9PC, resulting in ordered di- 
acetylenic domains and improving polymerization effi- 
ciency. One of the facts that contributes to this hypothe- 
sis is that these domains are more disordered than DC8, 
9PC domains, according to their gel-fluid transi- 
tion-temperature: being DMPC main transition tempera- 
ture is 23˚C, while that of DC8,9PC is 45˚C. In DMPC 
disordered domains, there are more water molecules in- 
teracting with the head groups, and, being L-tryptophan a 
water-soluble amino acid, it should be preferentially at 
the interface. 
3.2. In Vitro Release 
Encapsulation efficiency of L-tryptophan in the case of 
polymerized liposomes with 10 mol% of the amino acid 
was 19.81 ± 1.87 and in the case of 50 mol% it was 
17.11 ± 1.89. Although percentages are similar greater 
amount of amino acid was encapsulated in the case of 
incubation with a higher concentration of L-tryptophan. 
Releasing profiles are shown in Figure 4.   
Data corresponding to percentage of L-tryptophan re- 
lease are shown in Figure 4. Polymerized liposomes 
prepared in presence of 50 mol% of L-tryptophan re- 
leased less amino acid than in the case of polymerized 
liposomes prepared in presence of 10 mol% of L-tryp- 
tophan. Even though, both curves would be consider as 
an efficient controlled release system, 50 mol% of L-trp 
has 5 times concentration compared with 10 mol%. Ap- 
parently, high concentration of amino acid not only is 
useful for pharmacodynamics purposes, it can also stabi- 
lize lipopolymers. Polymerized liposomes were efficient 
in retaining the amino acid probably because of their 
high rigidity. L-tryptophan was probably in the hydro- 
philic region and in the aqueous spaces placed between 
lipid bilayers. The formulations used were multilamellar 
to increase amino acid encapsulation efficiency.  
3.3. FTIR Spectroscopy 
To corroborate the position of the amino acid in contact 
with lipid groups, the FTIR spectra of polymerized and 
non-polymerized liposomes were recorded to identify 
different interactions that could appear due to the poly- 
merization reaction. Spectra with the vibrational modes 
are shown in Figure 5.  
 
 
Figure 4. In vitro L-tryptophan release. Figure 3 shows the 
percentage of L-tryptophan released at different times, cal- 
culated as mentioned above. Data are presented as mean ± 
SD of three independent experiments. *Significant differ- 
ences respect to samples with 50 mol% of L-tryptophan 
after performing Tukey’s test (p < 0.05).  
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Figure 5. FTIR spectra of DC8, 9PC:DMPC liposomes and 
polymerized liposomes (top spectrum).  
 
The vibrational modes analyzed were reported by 
other authors [32]. Methylene symmetric stretching mode 
(2850 cm−1) and antisymmetric stretching mode (2920 
cm−1) are associated with changes in conformational or- 
der [33].  
Between 2800 and 3000 cm−1, the spectra showed two 
peaks: 2850 and 2920 cm−1, corresponding to methylene 
symmetric and antisymmetric stretching respectively. A 
decrease in the wavenumber of these bands is associated 
with an increase in the conformational order of the ali- 
phatic chains of the lipid, resulting from an increase in 
the number of trans conformers with respect to gauche 
conformers [33]. The polymerization process induced a 
decrease in these bands, demonstrating that lipopolymers 
have increased packing with respect to non-polymerized 
formulations.  
I Non-polymerized liposomes, have the -C=O stretch- 
ing band shifted towards smaller frequencies, which 
suggests higher hydration in the zone of the polar head 
near the beginning of the hydrophobic region [34]. This 
result is in accordance with those obtained in the deter- 
mination of the HF, where non-polymerized samples 
exhibited a higher number of surface defects (i.e. higher 
HF). Also, the hydrogen bonding established with water 
molecules in non-polymerized liposomes was higher, as 
the -C=0 stretching band is shifted towards smaller fre- 
quencies.  
In alkynes, the carbon stretch (632 cm−1) is missing in 
polymerized liposomes because the triple bond reacts to 
form double bonds. The absence of this band in polym- 
erized liposomes has also been reported by other authors 
[32].  
FTIR spectra were also recorded in polymerized lipo- 
somes with and without L-tryptophan. Absorbance data 
are shown in Table 1.  
Table 1. Peak positions in polymerized liposomes with and 
without L-tryptophan.  
Vibrational mode Polymeric liposomes Polymeric liposomes with L-tryptophan 
–CH2 2851 2920 2850 2920 
–C=O 1732 1732 
–C=C– 1634 1635 
–CH3 1470 1467 
–POOH 1236 1236 
–NH3+ 846 983 1068 858 972 1070 
 
In the case of POOH vibrational modes, the position of 
the peak is sensitive to the formation of H-bonds or cou- 
lombic interactions, shifting to lower frequencies with 
increasing bonding [35]. Non-polymerized liposomes ex- 
hibited more H-bonding in POOH vibrational mode than 
polymerized ones (Figure 3). This is probably because 
when lipids are closer to each other, like in the case of 
polymerized formulations, the charges of phosphate groups 
are probably being repelled and bonding avoided. The 
presence of L-tryptophan had no influence on -POOH vi- 
brational mode (Table 1), which suggests that this amino 
acid interacts with the interphase through other groups, 
but not through -POOH.  
Also, L-tryptophan had no influence on -C=O or -CH2 
vibrational modes, but changed the vibrational mode of 
-CH3 (1470 cm−1). In this way, the L-tryptophan that 
interacts at the interface prolongs its influence up to the 
end of the acyl chain. This, L-tryptophan may induce 
chain interdigitation: interacting at the surface of the bi- 
layer, bringing apart some of the lipid headgroup mole- 
cules, modiyfng the environment from the surface down 
into the hydrophobic core, hence changing the vibra- 
tional mode of the -CH3 groups, causing lipid interdigi- 
tation [36,37,38].   
In the case of -NH3+ vibrational modes, several 
changes were induced by the polymerization process and 
by differential amino acid content. Polymerization in- 
duced the 980 cm−1 band shifts toward higher frequencies; 
this band corresponds to amine skeleton vibration [39] 
and a higher frequency reflects minor mobility, so 
-NH3+ has less freedom degree as a consequence of 
more rigid surface in polymerized liposomes than in 
non-polymerized ones. This result is along with those of 
HF data: polymerized liposomes showed lower HF than 
non-polymerized ones, which means that polymerized 
liposomes are more rigid at the interphase than non-po- 
lymerized ones. When L-tryptophan is present, the 
amines skeleton acquires more movement because the 
amino acid interacts with phosphatidylcholine head 
groups through the amines, decreasing the amine phos- 
pholipid group degrees of freedom.    
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This interaction is so strong that it prevents L-trypto- 
phan from being released from the lipopolymer, as re- 
flected in the release assay; only around 20% of the 
amino acid is released.   
Also, in polymerized liposomes with L-tryptophan 
there are no modifications in the order of the acyl chains 
respect to polymerized samples without the amino acid 
(2850 and 2920 cm−1 bands, Table 1). This could be be- 
cause, as previously described, polymerized DC8, 9PC is 
only 20% of the total diacetylenic lipid [8] and this low 
percentage did not induced changes in FTIR spectra.  
3.4. Cell Metabolism Activation 
To study if the polymerized liposomes containing L- 
tryptophan influence metabolism and can induce cyto- 
toxic effects, an MTT assay was performed in Caco-2 
cells. The liposome concentration in all assays was 1 
mg/ml. Untreated cells were used as controls. Liposomes 
and L-tryptophan without liposomes were also tested. 
Results are shown in Figure 6.  
Polymerized liposomes can induce a mild metabolic 
activation, which is maintained after 24 hours. This has 
also been reported for other cell lines in the case of po- 
lymerized liposomes [24].  
When L-tryptophan concentration is 10 mol% respects 
to total lipid concentration, a high metabolic activation is 
induced in the absence and presence of polymerized li- 
posomes after 4 hours treatment. . Prolonging the treat- 
ment for 24 hours led to a large effect: 50% of the cell 
culture showed no metabolic activity in the presence of 
free L-tryptophan. However, when the tryptophan was 
encapsulated in polymerized liposomes, the cytotoxic 
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Figure 6. Cell metabolism activation. Figure 6 shows meta- 
bolic activation of cells treated with polymerized liposomes 
and different L-tryptophan concentrations. Untreated cells 
were taken as a control. Data are presented as mean ± SD of 
three independent experiments. The dotted line indicates 
metabolic activation higher than 100% respect to the con-
trol.  
ture had no metabolic activity.  
The indole side chain of tryptophan is a nitrogen-con- 
taining heterocycle, a hydrogen bond donor and an elec- 
tron-rich aromatic system [13]. Since cell metabolism 
was measured by the activity of mitochondrial reductases, 
one hypothesis is that since tryptophan is an electron-rich 
amino acid, it can induce higher reductase activity after 4 
hours because of its oxidative activity. When tryptophan 
was encapsulated in polymerized liposomes, reductase 
activity effect after 24 hours increased, probably as a 
result of the amino acid protection by polymerized lipo- 
somes.   
In the case of L-tryptophan 50%, metabolic activation 
remained unmodified after 4 hours but increased when 
the amino acid was encapsulated in polymerized lipo- 
somes. This is probably because of a combined effect: 
metabolic activation of polymerized liposomes and high 
L-tryptophan concentration. As mentioned before, po- 
lymerization in the presence of high L-tryptophan con- 
centration is more efficient, leading to a more concen- 
trated polymer, and this polymer could have more influ- 
ence on metabolic activity than the one generated with 10 
mol% of L-tryptophan.  
After 24 hours, cells treated with high L-tryptophan 
concentrations presented high metabolic activity, while 
when tryptophan was encapsulated in polymerized lipo- 
somes, around 70% of the cell culture had reductase ac- 
tivity. This effect was probably because of the degrada- 
tion pathway of the L-tryptophan. Indoleamine 2,3-di- 
oxygenase (IDO) is a heme-containing dioxygenase which 
catalyzes the first and rate-limiting step in the main path- 
way of L-tryptophan catabolism in mammals. Much at- 
tention has been recently paid to dioxygenase because 
this metabolic pathway is involved in a variety of physi- 
ological functions [40]. Tryptophan catabolism through 
the IDO pathway is probably involved in the production 
of antioxidant molecules [41]. These antioxidant mole- 
cules could induce a decrease in the antioxidant activity 
of the mitochondrial dehydrogenases, which is measured 
with the MTT assay. This effect was observed only in the 
case of 50 mol% of L-tryptophan respect to total lipid 
concentration probably because of the high amino acid 
concentration.   
Overall, polymerized liposomes did not induce high 
cytotoxic effects in Caco-2 cells, which makes them se- 
cure to apply as vehicles for molecules such as L-tryp- 
tophan.  
4. Conclusions 
Polymerized liposomes proposed as amino acid vehicles 
showed to be able to encapsulate high concentrations 
of L-tryptophan. This amino acid also induced higher 
polymerization efficiency, as a result of an increase in 
packing of the polar region area.   
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Polymerized liposomes were also able to retain around 
80% of the L-tryptophan added, even when L-tryptophan 
concentration was 50 mol% relative to total lipid.  
When polymerized liposomes are in contact with cells 
belonging to absorbent epithelia, they do not modify the 
metabolic activity significantly, resulting in a secure drug 
delivery system that could be applied to improve the 
pharmacodynamics of L-tryptophan.   
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